Dr Reddy’s Labs gets CDSCO nod for Zytorvi use in esophageal squamous cell carcinoma | Hyderabad News
Hyderabad: Dr Reddy’s Laboratories said on Wednesday that the Indian drug regulator has approved Zytorvi, its toripalimab, with cisplatin and paclitaxel as a first-line treatment for adults with unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma (ESCC).The approval by the Central Drugs Standard Control Organisation (CDSCO), under the Drugs Controller General of India (DCGI),…
